{
  "id": 7037479,
  "title": "Akeso details survival win for its PD-1xVEGF drug versus Keytruda",
  "url": "https://urgent.news/2026/09/13/akeso-details-survival-win-for-its-pd-1xvegf-drug-versus-keytruda",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-13T01:46:49.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/akeso-details-survival-win-for-its-pd-1xvegf-drug-versus-keytruda/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Akeso and Summit Therapeutics claimed a key win over Keytruda at the start of September, and are now spelling out that survival data. They hope it will add to the trove of results supporting the ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}